New technique may help treat diabetes

The same technology that creates computer microchips may one day help treat diseases such as diabetes, says an Ohio State researcher.

Mauro Ferrari, professor of biomedical engineering at OSU, has devised a method for implanting tiny silicon capsules - about the size of a pinhead - beneath a patient's skin.

Such capsules would carry healthy transplant cells that would take the place of the patient's malfunctioning cells by producing needed chemicals for the body. For example, capsules in diabetics could allow patients to produce insulin again, Ferrari explained.

Mauro Ferrari

Today, doctors suppress patients' immune systems with drugs to keep antibodies from destroying transplanted tissue, leaving patients open to infections. Ferrari's technique eliminates the need for immunosuppression, and for transplanting an entire organ when a few grams of healthy cells will do.

"If you can't beat the immune system, you hide from it," said Ferrari. He and his colleagues are working to make capsules with holes that are just the right size - big enough to let needed chemicals get out, but small enough to keep antibodies from getting in.

In their latest study, Ferrari and his colleagues were able to create 2-millimeter capsules, each containing millions of channels only 18 nanometers - approximately 50 atoms - across.

The researchers simulated the capsule's use in treating insulin-dependent diabetes. The 18-nanometer holes allowed glucose and insulin molecules to pass through, but blocked the antibody immunoglobulin G (IgG), which attacks transplanted cells.

These results were published in a recent issue of the Journal of Membrane Science.

Ferrari began his research before he became director of Ohio State's Biomedical Engineering Center, while still on the faculty of the University of California at Berkeley.

Co-authors of the study are Tejal Desai and Derek Hansford, former students of his at Berkeley. Desai is now assistant professor of bioengineering at the University of Illinois at Chicago, and Hansford joined the Ohio State faculty as an assistant professor of biomedical engineering in August.

Insulin-dependent diabetes develops when the body fails to recognize cells in the pancreas that respond to glucose and produce insulin.

One possible therapy is to transplant even just a few grams of healthy pancreatic cells, Ferrari explained. A capsule containing the cells could be inserted under the skin anywhere in the body. Molecules of glucose would enter the capsule, and the transplanted cells would release insulin, which would flow back out.

Ferrari and his colleagues inserted a silicon membrane containing 18-nanometer holes between two chambers of liquid, one containing IgG. Over the next four days, they measured the amount of IgG that penetrated the membrane.

After one day, the concentration of IgG in the second chamber was less than 0.4 percent. After four days, the concentration had grown to just over 1 percent.

Ferrari characterized this rate as several times slower than capsules made of plastic. He cited a similar study in which a perforated plastic membrane allowed an IgG concentration of 1 percent to accumulate in the second chamber after only 24 hours.

Ferrari said that keeping out 100 percent of all IgG may be impossible. Researchers think the molecule is not spherical, and if it enters an opening with its narrow end, it can squeeze through.

"These molecules twist and turn and find their way into small passageways - that's what makes them good antibodies," said Ferrari.

Ferrari said that one capsule could produce all the insulin a patient needed for a year for about $20. He hopes to be able to test his capsules in clinical trials within the next three years.

Ferrari and his colleagues recently received a $1.4 million grant from the Ohio Board of Regents to continue this work in a consortium. Besides OSU, other member institutions include Case Western Reserve University, University of Cincinnati, University of Akron, the Cleveland Clinic Foundation, and Battelle Memorial Institute.

The Office of University Relations produces articles about faculty research to distribute to the national media. Among the most recent stories:

Marriage rates differ slightly in childhood cancer survivors

Children who survive cancer have a slightly lower rate of marriage when they reach adulthood than the general population, although the rate varies somewhat by sex and race, new research shows. Among survivors aged 40 and above, 90 percent of female cancer survivors had been married, compared with 91.3 percent in the general population. Among males in the same age group, 92 percent of survivors were married versus 86 percent in the general population. The lead author of the study was Amanda Rauck, clinical assistant professor of pediatrics. www.acs.ohio-state.edu/units/research/archive/childca.htm

Bioterrorism may be threat to U.S. agriculture, expert says

What would happen if someone deliberately infected an agricultural crop with a pathogen? It hasn't happened in the United States yet, but experts think that it can, and they're now beginning to look at the risk. Larry Madden, a professor of plant pathology, said at a recent conference that experts need to begin identifying which pathogens would pose the greatest threat to American agriculture if used by bioterrorists. www.acs.ohio-state.edu/units/research/archive/croppat1.htm